RAPID Alliance 2.0 Launch and Innovation Acceleration Forum

Tuesday, 21 June 2022 11:00 AM - 7:00 PM [EDT]

Register Now

1. Select Seats

2. Review and Proceed

Days
Hours
Minutes
Seconds

Registration

Sale ended

Complementary pass (requires guest code) Partial Approval - Free

sales ended

All-events pass Partial Approval - $100.00

Fees help cover the costs of organizing the event. All funding goes to Intrinsica, a non-profit organization committed to advancing the public good.

Sale ended

Student pass Partial Approval - $25.00

Enter your discount code

  • Subtotal (excluding fees and discounts)
  • Fee
  • Total amount

Tuesday, 21 June 2022 11:00 AM - 7:00 PM [EDT]

Please join us in using a deep ethics driven approach to help solve one of the hardest problems in healthcare, the non-optimized use of medications and vaccines.  Our goal is to raise and deploy up to $5 billion dollars to help improve health and wellbeing for 200 million+ people, save up to $200 billion per year, and create billions in new market value in this space by 2031

For people who are disatisfied with the current rate of change in this space, the RAPID Alliance at Intrinsica is organizing an innovation community designed to accelerate innovation at scale in order to optimize use of medications and vaccines in the US and beyond. 

The platform works by bringing together key stakeholders from across the ecosystem, in both public and private sectors, to solve problems no one party can solve alone.  What makes it unique is how it combines 7 key elements: deep ethics, cutting edge science, advanced technologies, a collaborative funding model,  collaborative policy development, community-based multi-stakeholder governance, and a shared commitment to improving health and wellbeing for all people.   

In this event, we will be kicking off this platform, welcoming key partners, reviewing the strategic plan, and hearing innovation project proposals from a number of presenters.  Innovation projects we support can be public sector, private sector or and hybrid (e.g. platform utilities of value to both sides). 

The discussion will include plans to generate funding of $25M in 2022, growing to several hundred million per year by 2031, to accelerate innovation in this space.

Benefits of Attending this Event

As a participant, you will:

 

Hear How the RAPID Alliance and Intrinsica Got Started and the Science Behind this Opportunity

 

Judah Thornewill, PhD

Chief Science Officer

Intrinsica, Inc. 

 

Learn about the History and Future of the Space from RAPID Alliance Emeritus Brigade Members - some of the most distinguished academic leaders in the field

 

 

Gain Insights about Emerging Trends from Nationally Recognized Leaders 

 

Lucinda Maine, PhD

Executive Vice President and Chief Executive Officer (Retiring)

American Association of Colleges of Pharmacy

 

Lee Vermeulen, M.S., FCCP, FFIP 

Executive Vice President and Chief Executive Officer (Incoming)

American Association of Colleges of Pharmacy

 

Ben Bluml, RPh

Senior Vice President for Research and Innovation 

American Pharmacists Association

Donney John, PharmD 

Non-profit leader 

 

Learn about plans to generate up to $5 billion in new funding to support innovation from now through 2031

Includes plans to deploy collaborative funding from organizational partners, foundations and philanthropy, government, private-equity and blockchain (Web3) platforms.

Tom Walton, MDiv, MS

Chief Executive Officer 

Intrinsica, Inc

Hear Transformational Innovation Pitches for High Priority Areas from Our First Group of Researchers and Innovators

 

 

 

Connect with Leading Researchers in the Space from our National Network of Participating Universities 

  

 

Gain Opportunities to Fund or Partner in Innovations 

You’ll identify opportunities to fund or partner with transformational innovation opportunities, and/or to help accelerate other innovation opportunities usin this methodology.

Event Objectives

Objective 1.  Convene RAPID Alliance 2.0 All-Stakeholder Community 

Objective 2.  Bring together transformational innovators,  partners and funders to begin the process of accelerating innovation (public and private sector) to optimize use of medications in the US and beyond. 

Objective 3. Support implementation of innovations that can make a difference. 

Objective 4.  Help people and organizations make new connections 

Please note. This is our first transformational innovation forum. We are co-creating the  best ways to do this. We will appreciate  input on how we can improve for the next one. We plan to do more of these at least quarterly .  

Agenda   

Tuesday, June 21 2022.  

11am-12pm EDT:  RAPID Alliance 2.0 Launch Meeting 

12:00 - 12:20 EDT:  Q&As / Open Discussion

12:20  - 1:00:  Deploying Billions to Save Hundreds of Billions:  A 21st Century Strategy for Funding Medications Sector Innovation

1:00pm - 4:30pm. Innovation Pitches (every 15 minutes)

4:30 - 6:00pm.  Medipreneurs Workshop: co-creating the world's leading health entrepreneurship network

6:00 - 7:00pm EDT.  Virtual meet and greet in Wonder Room.

Follow-up Breakout Meetings to Be Scheduled in July and August

 

Who Should Attend?

Key stakeholders in the US medications and vaccines ecosystem with an interest in rapidly accelerating innovation to solve the $528 billion medications use challenge in the US, are invited and encouraged to attend, or have other colleagues attend, this event. Participation by leading stakeholders from both the public and private sectors, representing all key sectors and professions, is a critical success factor for this effort.  

  • If you are a public sector funder (foundation, philanthropy, or individual donor), please attend this event to help to identify, fund and support transformational innovations. You'll also have opportunities to join as a Funding Partner or Funding Catalyst. 
  • If you are an equity investor (private, VC, PE, or Institutional), we are organizing a special for-profit Intrinsica Investor Network and exploring development of new funds to provide advanced access to deal flow, and accelerate investment in promising innovations appropriate for private-sector growth. We expect to help existing organizations with promising innovations reduce risk and grow faster; and help identify and advance new transformational business opportunities. As a non-profit, Intrinsica supports all investment opportunities aligned with its mission. 
  • If you are a Web3.0 / Blockchain investor or innovator please join us to explore opportunities to co-create new platforms using these technologies. 
  • If you are a healthcare organization - pharmacist association, pharmacy, physician group, health plan, plan sponsor, health system, aging care, pharma, public health, lab, government agency, research university, or other stakeholder interested in optimizing use of medications, please join us to help identify, develop and implement transformational innovations that can benefit your organization or sector.  
  • If you are an innovator with an interest in advancing transformational innovations in this space, we want to help you accelerate your effort. In general we seek innovations that can impact at least 1 million people and 1 billion dollars in annual value within 1 decade (the 1:1:1) model. 
  • If you are a research university we have opportunities for you to receive funding as a catalyst to provide research and services to accelerate innovation in the space.
  • If you are an association we have opportunities for you receive funding as a catalyst to accelerate innovation in the space. 
  • If you are a consulting firm we have opportunities for you receive funding as a catalyst to accelerate innovation and implementation in the space. 
  • If you are a technology-platform or company (big-data, analytics, AI, collaboration tech, health tech, apps, devices) we want to provide you with ability to connect and collaborate with markets, more rapidly advance innovations, add partners and investors to help focus your efforts, and leverage up existing infrastructures in this space.  
  • If you are a government leader (federal, state, local) we welcome you as honored guests and subject matter experts.  We invite you to learn about our new approaches for public-private collaboration to improve the public good. We also welcome you to share insights about current policies, and opportunities for grants, contracts, or other funding that may be available to help advance this work.  Government funding can be provided directly through Intrinsica, or through our network of catalysts at universities, associations, or non-profits.
  • If you are a wellbeing advocate, your participation is critical, to ensure that individual/family voices are represented and included in all decisions. 
  • If you are in any other role in the field, including being a student, and are interested in helping co-create the future of medications and vaccines, you are welcome.

Thank you to our founding sponsor

Thank you to Sanofi for 2021 support that helped make this event possible. 

   

Intrinsica, Inc.

https://www.intrinsica.org

The RAPID Alliance is part of Intrinsica, a non-profit organization whose mission is to rapidly accelerate innovation to solve hard problems requiring multi-sector collaboration. The mission of the RAPID Alliance is to rapidly accelerate innovation to optimize use of medications and vaccines. This is a $528 billion opportunity space with a market size of 200 million+ people in the US, and billions worldwide.

Contact the Organizer View other events

Tom Walton
CEO
Intrinsica

About Tom Walton

CEO
Intrinsica
Jay Lee
Professor,
University

About Jay Lee

Professor,
University
Heather Anderson, PhD
Associate Professor, Pharmaceutical Outcomes Research PhD Program Director
University of Colorado Anschutz

About Heather Anderson, PhD

Associate Professor, Pharmaceutical Outcomes Research PhD Program Director
University of Colorado Anschutz
Lihui Bai, PhD
Associate Professor
University of Louisville

About Lihui Bai, PhD

Associate Professor
University of Louisville
Gayle Brazeau, PharmD
Dean
Marshall University

About Gayle Brazeau, PharmD

Dean
Marshall University
Michelle Fritsch, PharmD
Director, Emeritus Brigade and Medipreneurs
Medipreneurs and Emeritus Brigade

Former Chair, Notre Dame of Maryland University School of Pharmacy. Founder, Retirement Wellness Strategies, Medipreneurs, Emeritus Brigade.

https://sites.google.com/starstudy.link/077emeritusbrigade/home

About Michelle Fritsch, PharmD

Director, Emeritus Brigade and Medipreneurs
Medipreneurs and Emeritus Brigade
Van Hellerslia, PharmD
Clinical Associate Professor
Temple University

About Van Hellerslia, PharmD

Clinical Associate Professor
Temple University
Michael Hogue
Dean
Loma Linda University

About Michael Hogue

Dean
Loma Linda University
Donney John
Executive Director
NOVA ScriptsCentral

About Donney John

Executive Director
NOVA ScriptsCentral
Alex Lin, PhD
Director, Associate Professor
University of Cincinnati

Alex C. Lin, Ph.D., is Associate Professor of the James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio. Dr. Lin’s expertise is in pharmacy automation technologies, and large data analysis. He has been a consultant/advisor to many of major US, Japanese, Taiwanese and international chain drugstores, pharmaceutical wholesalers and healthcare enterprises/institutes. Some of these US companies include McKesson APS, Procter and Gamble Healthcare, Kroger Co., NIH outpatient pharmacy, and Pyxis Corp, Baxter Healthcare. Internationally, Dr. Lin has worked with All Japan Drugstore (AJD), Oriex Drugstores, Taiwanese company/institute of Uni-President Enterprises Group, and Ministry of Health, and the Egyptian company of El Sewedy Enterprises. Dr. Lin’s credentials include his involvement with the Pyxis Corporation in developing the Pyxis MedStation (a computerized medication control system) from product concept to beta-site evaluation between 1985 and 1990.

About Alex Lin, PhD

Director, Associate Professor
University of Cincinnati
Karen MacKinnon, PharmD
Director of Outreach Programs, Assistant Professor, Director, Vaccine Advancement 360 Initiative in RAPID Alliance
Medical College of Wisconsin

About Karen MacKinnon, PharmD

Director of Outreach Programs, Assistant Professor, Director, Vaccine Advancement 360 Initiative in RAPID Alliance
Medical College of Wisconsin
Lucinda Maine
EVP and CEO American Association of College of Pharmacy (Outgoing)
American Association of Colleges of Pharmacy

About Lucinda Maine

EVP and CEO American Association of College of Pharmacy (Outgoing)
American Association of Colleges of Pharmacy
Kathryn Momary, PharmD
Vice Chair of the Department of Pharmacy Practice, Associate Professor of Pharmacy Practice, Associate Professor of Pharmaceutical Sciences,
Mercer University

About Kathryn Momary, PharmD

Vice Chair of the Department of Pharmacy Practice, Associate Professor of Pharmacy Practice, Associate Professor of Pharmaceutical Sciences,
Mercer University
Gina Moore, PharmD, MBA.
Associate Dean for Operations; Associate Professor
University of Colorado Anschutz

About Gina Moore, PharmD, MBA.

Associate Dean for Operations; Associate Professor
University of Colorado Anschutz
Brittany Riley, PharmD
Assistant Professor
Marshall University

About Brittany Riley, PharmD

Assistant Professor
Marshall University
John Roll, PhD
Professor and Vice President for Research, Founding Director of the WSU Program of Excellence in Addictions Research
Washington State University

About John Roll, PhD

Professor and Vice President for Research, Founding Director of the WSU Program of Excellence in Addictions Research
Washington State University
Todd Sorenson, PharmD
Professor
University of Minnesota

About Todd Sorenson, PharmD

Professor
University of Minnesota
Lee Vermeulen, M.S., FCCP, FFIP
Executive Vice President and Chief Executive Officer (Incoming)
American Association of Colleges of Pharmacy

About Lee Vermeulen, M.S., FCCP, FFIP

Executive Vice President and Chief Executive Officer (Incoming)
American Association of Colleges of Pharmacy
Georg F. Weber, MD, PhD
Professor
University of Cincinnati

About Georg F. Weber, MD, PhD

Professor
University of Cincinnati
William Yasnoff, MD, PhD
Adjunct Professor, President; Co-Facilitator, RAPID Alliance Life Data 360 Platform Initiative.
Johns Hopkins University; NHII Advisors

About William Yasnoff, MD, PhD

Adjunct Professor, President; Co-Facilitator, RAPID Alliance Life Data 360 Platform Initiative.
Johns Hopkins University; NHII Advisors
Judah Thornewill, PhD
Co-Founder and Chief Science Officer
Intrinsica, Inc.

Judah Thornewill is the Co-Founder and Chief Science Officer of Intrinsica, a non-profit administrator of ecosystem collaboratives for global wellbeing, with a vision of co-creating the world's largest wellbeing improvement network. He specializes in the science and practice of very large scale collaborations for improving the health and wellbeing of populations at national and global scales. Prior to his current role, he served as Principal Investigator and researcher in the National Science Foundation Center for Health Organization Transformation at the University of Louisville, in the School of Public Health and Information Sciences, where he continues to teach and do research on a part time basis.

https://www.intrinsica.org

About Judah Thornewill, PhD

Co-Founder and Chief Science Officer
Intrinsica, Inc.
Jonathan Watanabe, PharmD, PhD (Invited)
Professor
University of California, Irvine

About Jonathan Watanabe, PharmD, PhD (Invited)

Professor
University of California, Irvine

About Sanofi

www.sanofi.com Sponsor Logo

11:00 AM
Plenary Session

RAPID Alliance 2.0 Launch Meeting

11:00 AM - 12:00 PM
  • Judah Thornewill, PhD

    Co-Founder and Chief Science Officer

Sponsors

12:00 PM

Q&As | Open Discussion

12:00 PM - 12:20 PM
  • +1
  • Tom Walton

    CEO

12:20 PM

Deploying Billions to Save Hundreds of Billions: a 21st Century Strategy for Funding Medications Sector Innovation

12:20 PM - 01:00 PM
  • +1
  • Tom Walton

    CEO

01:00 PM
Innovation Pitch

Pitch 1. OMIP: The Platform for Optimizing Medication Interventions for Plans

01:00 PM - 01:15 PM
  • +2
  • Heather Anderson, PhD

    Associate Professor, Pharmaceutical Outcomes Research PhD Program Director

01:15 PM
Innovation Pitch

Pitch 2. Pharmacy 5.0+: A Platform for Accelerating the Development and Delivery of Mass-Personalized Pharmacy Services at Ecosystem-Scale

01:15 PM - 01:30 PM
  • +1
  • Alex Lin, PhD

    Director, Associate Professor

01:30 PM
Innovation Pitch

Pitch 3. Vaccine Advancement 360: A Platform for Saving Lives by Increasing Vaccine Uptake

01:30 PM - 01:45 AM
  • Judah Thornewill, PhD

    Co-Founder and Chief Science Officer

Sponsors

01:45 PM
Innovation Pitch

Pitch 4. PAI: The Pharmacy Accessibility Index: A New Gold Standard for Measuring Pharmacy Deserts and Identifying Interventions to Strengthen Community Pharmacy Accessibility

01:45 PM - 02:00 PM
  • +1
  • Lihui Bai, PhD

    Associate Professor

02:00 PM
Innovation Pitch

Pitch 5. Life Data 360: The "Visa" for Personal Data, Launching in the US Pharmacy Space

02:00 PM - 02:15 PM
  • William Yasnoff, MD, PhD

    Adjunct Professor, President; Co-Facilitator, RAPID Alliance Life Data 360 Platform Initiative.

02:15 PM
Innovation Pitch

Pitch 6. RHMP: The Rural Health and Medications Platform - Accelerating the Spread of Innovations for Optimizing Medications Use in Rural Environments

02:15 PM - 02:30 PM
  • Brittany Riley, PharmD

    Assistant Professor

02:30 PM
Innovation Pitch

Pitch 7. CP-VIP: The Community Pharmacy Value Improvement Platform

02:30 PM - 02:45 PM
  • Judah Thornewill, PhD

    Co-Founder and Chief Science Officer

02:45 PM
Innovation Pitch

Pitch 8. PUMA: the Platform for Unified Measurement of Medications Access, Use, Quality and Impact

02:45 PM - 03:00 PM
  • Judah Thornewill, PhD

    Co-Founder and Chief Science Officer

03:00 PM
Innovation Pitch

Pitch 9. True Equity: A Platform for Co-Creating and Sharing Innovations that Work to Strengthen Equitable Access to Medications for All People

03:00 PM - 03:15 PM
  • +1
  • Michael Hogue

    Dean

03:15 PM
Innovation Pitch

Pitch 10. The PCH Platform: The Innovation Platform for Improving Palliative Care and Hospice Services for Families During End of Life Care

03:15 PM - 03:30 PM
  • +1
  • Gayle Brazeau, PharmD

    Dean

03:30 PM
Innovation Pitch

Pitch 11. ICT-IP: The Individualized Cancer Treatment Innovation Platform

03:30 PM - 03:45 PM
  • Georg F. Weber, MD, PhD

    Professor

03:45 PM
Innovation Pitch

Pitch 12. Medipreneurs: Co-Creating the World's Leading Health Entrepreneurship Network

03:45 PM - 04:00 PM
  • Michelle Fritsch, PharmD

    Director, Emeritus Brigade and Medipreneurs

04:00 PM
Innovation Pitch

Pitch 13. Healing without Despair: Accelerating innovation to protect and improve the health and wellbeing of the healthcare workforce

04:00 PM - 04:15 PM
  • Donney John

    Executive Director

04:15 PM
Innovation Pitch

Pitch 14. The RITZ Platform: accelerating medication related innovation, education and transformation at community and state levels

04:15 PM - 04:30 PM
  • Todd Sorenson, PharmD

    Professor

04:30 PM
Innovation Workshop

Medipreneurs Workshop: Co-Creating the World's Leading Health Entrepreneurship Network

04:30 PM - 06:00 PM
  • Michelle Fritsch, PharmD

    Director, Emeritus Brigade and Medipreneurs

06:00 PM
Networking Event

Meet and Greet with Wonder Technology (Eastern US time zones).

06:00 PM - 07:00 PM
07:30 PM
Innovation Pitch

Placeholder. RAPIDHeal: An Innovation Acceleration Platform for Interventions for People Living with Addiction

07:30 PM - 04:45 PM
11:00 AM
Strategic Opportunities Workshop

Strategic Opportunities for US Health Sector Associations

11:00 AM - 12:00 PM
  • +1
  • Tom Walton

    CEO

12:30 PM
Strategic Opportunities Workshop

Strategic Opportunities for Universities

12:30 PM - 01:30 PM
  • +1
  • Tom Walton

    CEO

02:00 PM
Strategic Opportunities Workshop

Strategic Opportunities for Non-Profit and Government Funders

02:00 PM - 03:00 PM
03:00 PM
Strategic Opportunities Workshop

Strategic Opportunities for For-Profit Investors

03:00 PM - 04:00 PM
  • +1
  • Tom Walton

    CEO

04:30 PM
Plenary Session

Closing Plenary: Key Accomplishments, Next Steps, Thank You, Adjourn

04:30 PM - 05:30 PM
  • Integer nulla lorem, pellentesque eget eros malesuada, semper bibendum felis. Proin quis est egestas, ultrices purus tempor, aliquet erat. Nullam molestie, neque at hendrerit semper, dui lacus eleifend arcu, quis mattis augue leo condimentum dui. Nunc vehicula eleifend risus vitae luctus. Sed sed sem nibh. Nam sit amet massa ullamcorper, iaculis felis id, ullamcorper libero. Aenean aliquet orci quis nisi interdum faucibus. Maecenas sollicitudin, nunc vitae tempus feugiat, arcu elit egestas diam, sit amet maximus neque turpis ac quam. Curabitur at ligula eget turpis pellentesque vestibulum eu id ante. Cras eget turpis mauris. Vestibulum vitae quam elit. Suspendisse bibendum at ipsum nec tempor. Ut in tristique nibh. Aliquam erat volutpat. In hac habitasse platea dictumst.

    Vivamus tempor viverra enim, commodo faucibus quam porta sed. Sed et varius nunc. Fusce cursus sem nec tellus accumsan, sed laoreet nisi vulputate. Praesent varius quis turpis in aliquam. Phasellus nisl velit, porttitor eget risus sed, interdum elementum nibh. Praesent eget ante bibendum quam suscipit accumsan sit amet eu nisi. Ut eget facilisis risus. Proin molestie lorem ut interdum finibus. Sed pretium ut sapien at dictum. Sed sit amet dolor tincidunt turpis tincidunt ultricies et et neque.

    Nam non augue a lorem tempor sodales. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Quisque ullamcorper lobortis rhoncus. Morbi nec dui vitae odio ultricies posuere ac nec turpis. Vestibulum efficitur lectus sem, sed volutpat quam congue at. Nulla quis aliquam ex. Vestibulum eget felis consectetur, efficitur risus non, dapibus tellus. Aliquam ac gravida dui. Donec vel est a arcu tristique egestas id vitae neque. Nullam varius odio eget leo porttitor, pharetra rhoncus quam dignissim..